Soft Tissue Tumors Clinical Trial
Official title:
Quantitative MR Biomarkers for Sarcoma Treatment
To determine if MRI imaging can be used to accurately determine if a sarcoma is responding to the type of chemotherapy being used.
The purpose of this study is to determine if MRI imaging can be used to accurately determine if a sarcoma is responding to the type of chemotherapy being used or if it is ineffective early on in the treatment; instead of finding this out 2-3 months later. If it is determined that MRI can accurately diagnose tumor response, medications can be switched early on potentially improv8ing the patients'chances of recovery. ;
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT02834585 -
Magnetic Resonance Imaging or Ultrasound in Soft Tissue Tumors (MUSTT)
|
N/A | |
| Completed |
NCT01630239 -
MR-Guided Laser Ablation of Hepatic Tumors
|
Phase 0 |